Patents Assigned to Shire Pharmaceuticals Inc.
  • METHODS OF TREATMENT USING AN AMPHETAMINE PRODRUG
    Publication number: 20200155687
    Abstract: Disclosed are methods of treatment of various conditions and disorders, and symptoms associated therewith, including, for example, fatigue and/or inattention associated with various conditions and disorders, using homoarginine-amphetamine prodrug and/or conjugate, or salts thereof.
    Type: Application
    Filed: April 10, 2018
    Publication date: May 21, 2020
    Applicant: Shire Pharmaceuticals Inc.
    Inventors: Brigitte A. ROBERTSON, Norman W. BARTON
  • PRODRUGS OF OPIOIDS AND USES THEREOF
    Publication number: 20110190267
    Abstract: The present invention concerns prodrugs of opioid analgesics and pharmaceutical compositions containing such prodrugs. Methods for providing more consistent pain relief by increasing the bioavailability of the opioid analgesic with the aforementioned prodrugs are provided. The invention also provides for decreasing the adverse GI side effects of opioid analgesics.
    Type: Application
    Filed: December 23, 2010
    Publication date: August 4, 2011
    Applicant: Shire Pharmaceuticals, Inc.
    Inventors: Richard Franklin, Karl Swift, Bernard T. Golding, Robert G. Tyson
  • Transdermal Delivery of Meptazinol
    Publication number: 20070224253
    Abstract: A delivery system for the delivery of a salt of meptazinol or meptazinol precursor which increases the bioavailability of meptanizol by an effective amount to provide analgesic relief is disclosed. One embodiment of the delivery system is a transdermal device which increases the skin flux of meptazinol by an effective amount to provide analgesic relief. Also disclosed are methods of providing analgesic relief.
    Type: Application
    Filed: December 21, 2006
    Publication date: September 27, 2007
    Applicant: Shire Pharmaceuticals Inc.
    Inventor: Richard Franklin